Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Anthony McCamish Insider Profile
11 Followers
Mark Anthony McCamish, SVP & CMO at PDL BioPharma, holds 14.92K shares in PDL BioPharma (Ticker: PDLI), holds 78.03K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 60.24K shares in Rafael Holdings (Ticker: RFL). Most recently, Mark Anthony McCamish ― shares of PDL BioPharma on ― for an estimated value of ―.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+11.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Anthony McCamish holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 18, 2020 - Sep 18, 2021
Return:+35.20%
The most profitable trade made by Mark Anthony McCamish
Mark Anthony McCamish's Trading History
PDL BioPharma
―
―
―
$36.86K
Forty Seven
Apr 07, 2020
―
Uninformative Sell
―
$0.00
Avadel Pharmaceuticals
Aug 01, 2024
Director
Uninformative Buy
―
$788.83K
Vincerx Pharma Inc
―
Director
―
―
Rafael Holdings
Jan 08, 2024
Director
Uninformative Buy
50.06K
$108.43K
List of latest transactions for each holding click on a transaction to see Mark Anthony McCamish's performance on stock
You May Also Like
Mark Anthony McCamish insider profile FAQ
What is the percentage of profitable transactions made by Mark Anthony McCamish?
The percentage of profitable transactions made by Mark Anthony McCamish is 50%.
What is the average return per transaction made by Mark Anthony McCamish?
The average return per transaction made by Mark Anthony McCamish is 11.80%.
What stocks does Mark Anthony McCamish hold?
Mark Anthony McCamish holds: PDLI, FTSV, AVDL, VINC, RFL stocks.
What was Mark Anthony McCamish’s latest transaction?
Mark Anthony McCamish latest transaction was an Uninformative Buy of ―.
What was Mark Anthony McCamish's most profitable transaction?
Mark Anthony McCamish’s most profitable transaction was an Informative Buy of AVDL stock on September 18, 2020. The return on the trade was 35.20%.
What is Mark Anthony McCamish's role in PDL BioPharma?
Mark Anthony McCamish's role in PDL BioPharma is SVP & CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.